We've marketed many thousands of doctor practices over the years, and our experience clearly shows that nothing wins doctors' hearts (and loyalty) like helping them to increase their bottom line.
Beginning April 19, 2002, however, most pharmaceutical companies discontinued virtually all significant efforts to assist doctors with their practices due to the PhRMA Code On Interactions With Healthcare Professionals.
Today, aside from a few former "professional gift recipients," most people agree that the voluntary code was a positive development for the industry. In addition to providing appropriate ethical guidelines for interactions with doctors, it also helped curb the then-growing pharmaceutical "arms race" to win busy doctors' attention.
Still, underlying problems remain.
Today, pharmaceutical companies face even more competition to win doctor attention and loyalty, while doctors face an even more difficult practice environment.
Clearly many doctors would appreciate practice marketing help sponsored by a pharmaceutical company like yours, but how?
New, ethical strategies to help your pharmaceutical company stand out from the crowd and win market share
We've done a lot of due diligence on this issue, and we have come up with several breakthrough marketing ideas that we think you'll agree not only work, but are also highly likely to win the approval of your ethics counsel.
Because these ideas are both unique and proprietary, we cannot publish them here on the Internet. Instead, please contact us to find out more.
We promise it will be worth your while.
Call Stewart Gandolf at (800) 656-0907.
Marketing a healthcare organization can be challenging - even painful if you don't approach it with the right knowledge, tools, and guidance. By reading about mistakes and lessons others have learned the hard way, you can boost your marketing effectiveness and take a shortcut to success. Discover how to avoid these "Seven Deadly Sins". Plus, join over 30,000 of your fellow healthcare providers with a free subscription to our Insight Newsletter.